MedTrace Logo

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test

NCT04689399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4697

Last updated 2021-03-30

No results posted yet for this study

Summary

This project aims to investigate the sensitivity and specificity of the rapid antigen test compared to RT-PCR test performed on samples from the nasopharynx and the anterior nasal cavity and the oropharynx, respectively.

Conditions

Interventions

DIAGNOSTIC_TEST

Standard Q COVID-19 Ag - test, produced by SD Biosensor INC.

Alle Danish citizens tested for infection with SARS-CoV-2 by swabs in the oropharynx, and subsequently analysis of the specimens by RT-PCR test at Testcenter Danmark's test centers will be included in the study. Participants will, in addition to the oropharyngeal swab they are already schedule for, be examined by a rapid antigen test.

Sponsors & Collaborators

  • Testcenter Danmark, Statens Serum Institut

    collaborator UNKNOWN

  • Copenhagen Emergency Medical Services

    collaborator UNKNOWN

  • Rigshospitalet, Denmark

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-26
Primary Completion
2021-03-25
Completion
2021-03-25

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04689399 on ClinicalTrials.gov